Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Phosphorus Ligands. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101090770B discloses a dual-ligand Rh-catalyzed system for asymmetric hydrogenation, delivering superior enantioselectivity and cost efficiency for API manufacturing.
Patent CN1599743A discloses novel tropp ligands enabling high-efficiency asymmetric hydrogenation. Ideal for pharmaceutical intermediate manufacturing with reduced costs.